How to use high-sensitivity cardiac troponin assays in everyday clinical practice

Johannes Mair, Fred S. Apple, Kristian Thygesen, Allan S Jaffe

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

High-sensitivity cardiac troponin (hs-cTn) assays are increasingly being employed in many countries, however a generally accepted definition of high-sensitivity is still pending. These assays enable cTn measurement with a high degree of analytical sensitivity which can be in the single digit concentration range of ng/L or below. These assays have a low coefficient of variation (CV) of ≤10% at the 99th percentile upper reference value which is the recommended medical decision limit. One of the most important advantages of these new assays is that they allow novel, more rapid approaches to rule in or rule out acute coronary syndromes (ACS) than is possible with the contemporary cTn assays still more commonly used in practice. hs-cTn is also more sensitive for the detection of myocardial damage unrelated to acute myocardial ischaemia. However, the increase in early diagnostic sensitivity of hs-cTn assays for ACS comes at the cost of a reduced specificity because more patients with acute or chronic myocardial injury without overt acute myocardial ischemia are detected then with contemporary cTn assays. As hs-cTn assays are increasingly being adopted in clinical practice and more hs-cTn assays are being developed, this chapter attempts to synthesize the available data to make recommendations for their routine use and to indicate where sufficient clinical data are still lacking.

Original languageEnglish (US)
Title of host publicationTroponin: Informative Diagnostic Marker
PublisherNova Science Publishers, Inc.
Pages61-72
Number of pages12
ISBN (Print)9781631177590, 9781631177576
StatePublished - Jan 1 2014

Fingerprint

Troponin
Acute Coronary Syndrome
Myocardial Ischemia
Reference Values
Wounds and Injuries

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Mair, J., Apple, F. S., Thygesen, K., & Jaffe, A. S. (2014). How to use high-sensitivity cardiac troponin assays in everyday clinical practice. In Troponin: Informative Diagnostic Marker (pp. 61-72). Nova Science Publishers, Inc..

How to use high-sensitivity cardiac troponin assays in everyday clinical practice. / Mair, Johannes; Apple, Fred S.; Thygesen, Kristian; Jaffe, Allan S.

Troponin: Informative Diagnostic Marker. Nova Science Publishers, Inc., 2014. p. 61-72.

Research output: Chapter in Book/Report/Conference proceedingChapter

Mair, J, Apple, FS, Thygesen, K & Jaffe, AS 2014, How to use high-sensitivity cardiac troponin assays in everyday clinical practice. in Troponin: Informative Diagnostic Marker. Nova Science Publishers, Inc., pp. 61-72.
Mair J, Apple FS, Thygesen K, Jaffe AS. How to use high-sensitivity cardiac troponin assays in everyday clinical practice. In Troponin: Informative Diagnostic Marker. Nova Science Publishers, Inc. 2014. p. 61-72
Mair, Johannes ; Apple, Fred S. ; Thygesen, Kristian ; Jaffe, Allan S. / How to use high-sensitivity cardiac troponin assays in everyday clinical practice. Troponin: Informative Diagnostic Marker. Nova Science Publishers, Inc., 2014. pp. 61-72
@inbook{b0197696bbc14f74a0d1c3c2de32da23,
title = "How to use high-sensitivity cardiac troponin assays in everyday clinical practice",
abstract = "High-sensitivity cardiac troponin (hs-cTn) assays are increasingly being employed in many countries, however a generally accepted definition of high-sensitivity is still pending. These assays enable cTn measurement with a high degree of analytical sensitivity which can be in the single digit concentration range of ng/L or below. These assays have a low coefficient of variation (CV) of ≤10{\%} at the 99th percentile upper reference value which is the recommended medical decision limit. One of the most important advantages of these new assays is that they allow novel, more rapid approaches to rule in or rule out acute coronary syndromes (ACS) than is possible with the contemporary cTn assays still more commonly used in practice. hs-cTn is also more sensitive for the detection of myocardial damage unrelated to acute myocardial ischaemia. However, the increase in early diagnostic sensitivity of hs-cTn assays for ACS comes at the cost of a reduced specificity because more patients with acute or chronic myocardial injury without overt acute myocardial ischemia are detected then with contemporary cTn assays. As hs-cTn assays are increasingly being adopted in clinical practice and more hs-cTn assays are being developed, this chapter attempts to synthesize the available data to make recommendations for their routine use and to indicate where sufficient clinical data are still lacking.",
author = "Johannes Mair and Apple, {Fred S.} and Kristian Thygesen and Jaffe, {Allan S}",
year = "2014",
month = "1",
day = "1",
language = "English (US)",
isbn = "9781631177590",
pages = "61--72",
booktitle = "Troponin: Informative Diagnostic Marker",
publisher = "Nova Science Publishers, Inc.",

}

TY - CHAP

T1 - How to use high-sensitivity cardiac troponin assays in everyday clinical practice

AU - Mair, Johannes

AU - Apple, Fred S.

AU - Thygesen, Kristian

AU - Jaffe, Allan S

PY - 2014/1/1

Y1 - 2014/1/1

N2 - High-sensitivity cardiac troponin (hs-cTn) assays are increasingly being employed in many countries, however a generally accepted definition of high-sensitivity is still pending. These assays enable cTn measurement with a high degree of analytical sensitivity which can be in the single digit concentration range of ng/L or below. These assays have a low coefficient of variation (CV) of ≤10% at the 99th percentile upper reference value which is the recommended medical decision limit. One of the most important advantages of these new assays is that they allow novel, more rapid approaches to rule in or rule out acute coronary syndromes (ACS) than is possible with the contemporary cTn assays still more commonly used in practice. hs-cTn is also more sensitive for the detection of myocardial damage unrelated to acute myocardial ischaemia. However, the increase in early diagnostic sensitivity of hs-cTn assays for ACS comes at the cost of a reduced specificity because more patients with acute or chronic myocardial injury without overt acute myocardial ischemia are detected then with contemporary cTn assays. As hs-cTn assays are increasingly being adopted in clinical practice and more hs-cTn assays are being developed, this chapter attempts to synthesize the available data to make recommendations for their routine use and to indicate where sufficient clinical data are still lacking.

AB - High-sensitivity cardiac troponin (hs-cTn) assays are increasingly being employed in many countries, however a generally accepted definition of high-sensitivity is still pending. These assays enable cTn measurement with a high degree of analytical sensitivity which can be in the single digit concentration range of ng/L or below. These assays have a low coefficient of variation (CV) of ≤10% at the 99th percentile upper reference value which is the recommended medical decision limit. One of the most important advantages of these new assays is that they allow novel, more rapid approaches to rule in or rule out acute coronary syndromes (ACS) than is possible with the contemporary cTn assays still more commonly used in practice. hs-cTn is also more sensitive for the detection of myocardial damage unrelated to acute myocardial ischaemia. However, the increase in early diagnostic sensitivity of hs-cTn assays for ACS comes at the cost of a reduced specificity because more patients with acute or chronic myocardial injury without overt acute myocardial ischemia are detected then with contemporary cTn assays. As hs-cTn assays are increasingly being adopted in clinical practice and more hs-cTn assays are being developed, this chapter attempts to synthesize the available data to make recommendations for their routine use and to indicate where sufficient clinical data are still lacking.

UR - http://www.scopus.com/inward/record.url?scp=84949524997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949524997&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:84949524997

SN - 9781631177590

SN - 9781631177576

SP - 61

EP - 72

BT - Troponin: Informative Diagnostic Marker

PB - Nova Science Publishers, Inc.

ER -